LINDA BADDOUR

CIK 1181151 · Executive VP & CFO · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.03M

Companies

5

Total Filings

45

Lifetime Open-Market Net

-$44.75M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CYRX Director 68,099 $14.62 $995.6K $0 11 2026-06-09
WAT Director 2,899 $355.53 $1.03M -$1.09M 13 2026-02-27
PRA Health Sciences, Inc. (PRAH) Delisted Executive VP & CFO 67,000 $165.21 $11.07M -$37.87M 11 2018-01-18
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted Former Chief Financial Officer 22,057 -$5.79M 8 2008-01-25
PRA International (PRAI) Delisted EVP and CFO $0 1 2007-06-06

Recent Filings · Page 2 of 5

45 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-03-17 CYRX Exer (M) +1,111 $0 EDGAR
2023-01-05 WAT Grant (A) +318 $0 EDGAR
2022-05-03 CYRX Mixed +9,911 $0 EDGAR
2022-03-16 CYRX Exer (M) +1,111 $0 EDGAR
2022-01-05 WAT Grant (A) +301 $109.7K EDGAR
2021-08-17 WAT Mixed -$284.2K EDGAR
2021-05-24 CYRX Exer (M) +341 $0 EDGAR
2021-05-14 WAT Mixed -$158.3K EDGAR
2021-05-07 CYRX Grant (A) $0 EDGAR
2021-03-17 CYRX Grant (A) $0 EDGAR
Showing 1120 of 45
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.